Sort   by:  
 Page size 
UnknownImpact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial.
Not available
S-EPMC6718524 | biostudies-literature
UnknownPrediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Not available
S-EPMC10950182 | biostudies-literature
UnknownFive-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
Not available
S-EPMC9437831 | biostudies-literature
UnknownGuidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations.
Not available
S-EPMC6244405 | biostudies-literature
Sort   by:  
 Page size